Stock Analysis

Photomyne Full Year 2023 Earnings: EPS: US$0.88 (vs US$0.38 loss in FY 2022)

Published
TASE:PHTM

Photomyne (TLV:PHTM) Full Year 2023 Results

Key Financial Results

  • Revenue: US$13.3m (down 18% from FY 2022).
  • Net income: US$2.50m (up from US$1.07m loss in FY 2022).
  • Profit margin: 19% (up from net loss in FY 2022). The move to profitability was driven by lower expenses.
  • EPS: US$0.88 (up from US$0.38 loss in FY 2022).
TASE:PHTM Earnings and Revenue History February 17th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Photomyne shares are up 11% from a week ago.

Risk Analysis

It is worth noting though that we have found 1 warning sign for Photomyne that you need to take into consideration.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.